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Abstract
Background: The involvement of muscle triacylglycerol (TAG) storage in the onset of insulin resistance is questioned and
the attention has shifted towards inhibition of insulin signalling by the lipid intermediate diacylglycerol (DAG). The enzyme
1,2-acylCoA:diacylglyceroltransferase-1 (DGAT1) esterifies a fatty acyl-CoA on DAG to form TAG. Therefore, the aim of the
present study was to investigate if unilateral overexpression of DGAT1 in adult rat Tibialis anterior (TA) muscle will increase
conversion of the lipid intermediate DAG into TAG, thereby improving muscle insulin sensitivity.
Methodology/Principal Findings: The DGAT1 gene construct was injected in the left TA muscle of male rats on chow or
high-fat (45% kcal) diet for three weeks, followed by application of one 800 V/cm and four 80 V/cm pulses, using the
contralateral leg as sham-electroporated control. Seven days after electroporation, muscle specific insulin sensitivity was
assessed with a hyperinsulinemic euglycemic clamp using 2-deoxy-[3H]glucose. Here, we provide evidence that unilateral
overexpression of DGAT1 in TA muscle of male rats is associated with an increased rather than decreased DAG content.
Strikingly, this increase in DAG content was accompanied by improved muscle insulin sensitivity. Interestingly, markers of
muscle lipolysis and mitochondrial function were also increased in DGAT1 overexpressing muscle.
Conclusions/Significance: We conclude that unilateral DGAT1 overexpression can rescue insulin sensitivity, possibly by
increasing DAG and TAG turnover in skeletal muscle. In case of a proper balance between the supply and oxidation of fatty
acids in skeletal muscle, the lipid intermediate DAG may not exert harmful effects on insulin signalling.
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Introduction
Obesity is characterized by excessive fatty acid mobilization,
giving rise to many obesity-related metabolic complications
including insulin resistance [1,2]. Indeed, a high rate of fatty acid
availability and subsequent uptake by skeletal muscle can augment
intramuscular lipid deposition [1,2], and there is a strong
correlation between the intramyocellular lipid (IMCL) concentra-
tion and the severity of insulin resistance, both in humans and
rodents [3,4,5,6]. However, evidence from the last decade
supports the hypothesis that IMCL accumulation does not directly
affect insulin action [7,8,9,10], rather other fatty acid intermedi-
ates, such as DAG, are proposed to impede insulin signalling
[11,12,13]. In fact, endurance trained athletes are considered
among the most insulin-sensitive people, despite having high
concentrations of IMCL; a finding that is referred to as ‘‘the
athlete’s paradox’’ [7,8,9,10]. Therefore, IMCL is considered a
reservoir for fatty acids that can be used for substrate delivery,
such as during exercise, and if IMCL accumulation is accompa-
nied by high fat oxidative capacity, detrimental effects of IMCL
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fatty acid flux, as with high-fat diets and obesity, limiting the
accumulation of detrimental fatty acid metabolites such as DAG
by improving the partitioning of fatty acids towards storage as
IMCL, is likely to blunt lipid related insulin resistance [9].
DGAT1 is a key enzyme that catalyzes the final step in
triglyceride synthesis. Overexpressing this enzyme results in
increased triglyceride synthesis, increased fatty acid oxidation
and preservation of insulin sensitivity despite the increased amount
of fatty acids offered to the muscle [14,15]. It has therefore been
suggested that elevated DGAT1 activity could be an explanation
for the athlete’s paradox. Indeed, Schenk and Horowitz [16]
showed that one acute bout of exercise leads to an increase in
DGAT1 expression and improved insulin sensitivity. Also in
rodents, exercise increases myocytic DGAT1 activity, and
transgenic overexpression of DGAT1 in skeletal muscle in mice
is sufficient to replicate the exercise paradox characterized by
increased muscle lipid content coupled with increased muscle
insulin sensitivity [14,17]. However, life-long muscle overexpres-
sion of DGAT1 may not resemble the situation that is observed
with endurance training, and may in fact lead to phenotypic
compensatory changes, such as a lower body weight that was
observed in mice overexpressing DGAT1 [14]. Therefore, we here
aimed to examine the impact of acute unilateral, muscle-specific
overexpression of DGAT1 in adult rats on skeletal muscle lipid
metabolism. To this end, we transiently overexpressed DGAT1 by
using gene electroporation in left TA muscle of adult rats while
using the right leg of the same animal as a sham-electroporated
control [18]. We hypothesized that overexpression of DGAT1 in
TA muscle of adult male Wistar rats would lead to an increase in
IMCL content and a decrease in DAG content, leading to
improved insulin sensitivity. Strikingly, we observed that DGAT1
overexpression was paralleled by an increased rather than
decreased DAG content yet improved insulin sensitivity. Interest-
ingly, key proteins in myocellular lipolysis and oxidative substrate
metabolism were increased upon DGAT1 overexpression.
Methods
Ethics statement
The experimental protocol was approved by the Institutional
Animal Care and Use Committee of Maastricht University and
complied with the principles of laboratory animal care (approval
number 2006-024). During the experiments all efforts were made
to minimize suffering of the animals.
Animals and diets
Twenty-two, eight-week old male Wistar rats were obtained
from Charles River Laboratories and were housed individually in
an environmentally controlled laboratory (temperature 2261uC
and relative humidity 5562%). Rats were randomly divided in
two groups and were allowed ad libitum access to food and tap
water. One group (n=10) received standard CHOW (10 energy
% as fat) (Ssniff, Germany) and the other group (n=12) received a
high-fat diet (HFD) that contained 45 energy % of fat derived from
lard (Research Diets, D01060502, Wijk bij Duurstede, The
Netherlands). Diets were provided for three weeks.
Cannulation
Two weeks before the end of the experiment the rats were
sedated under isoflurane anaesthesia and permanent indwelling
catheters were placed in the right jugular vein (for the sampling of
blood) and the left carotid artery (for the infusion of insulin and
glucose) under aseptic conditions. Both catheters were tunnelled
subcutaneously and exteriorized at the top of the head, where they
were attached. To maintain patency, the catheters were filled with
a mixture of 85% glycerol (Merck, Darmstadt, Germany) and 500
U/ml heparin (Leo Pharma BV, Breda, The Netherlands). All rats
regained pre-surgery body mass within 3 days.
Electroporation
One-week before the hyperinsulinemic euglycemic clamp
overexpression of mouse DGAT1 in the left Tibialis anterior
(TA) muscle of the rat was obtained, with the right TA as sham-
electroporated internal control. DNA electroporation was done
under isoflurane anaesthesia. Left TA muscles were transcuta-
neously injected with 150 mg( 2mg/ml) pcDNA sport DGAT1-
construct (pCMV-sport6, Invitrogen, Breda, The Netherlands) in
0.9% sterile NaCl. Right TA muscles were injected with 150 mg
(2 mg/ml) empty vector. Within 15 seconds after the last injection 5
electric pulses were applied by two stainless steel plate electrodes
placed at each side of the leg to obtain transient permeabilization
of the cell membrane, facilitating the passage of the DNA. One
high voltage pulse of 800 V/cm and four low voltage pulses of
80 V/cm at 1 Hz were generated by an ECM 830 electroporator
(BTX, San Diego) as described before [19,20,21]. Shaving the leg
and the application of conductive gel minimized impedance.
Hyperinsulinemic euglycemic clamp
Hyperinsulinemic euglycemic clamping of conscious rats was
performed after a 6 h fast. A primed continuous infusion of insulin
(Actrapid HM; Novo Nordisk, Copenhagen, Denmark) was
administered at a rate of 13 mU/kg/min for 120 min. Blood
glucose values were monitored at 10-min intervals throughout the
clamp. The glucose infusion rate (GIR) was adjusted to maintain
blood glucose concentration within the range of 4.5–5.5 mmol/L.
Insulin stimulated glucose disposal in vivo within the individual TA
muscles was studied according to a previously described method
[22]. Upon completion of the clamp, the rats were killed with an
overdose of sodium pentobarbital and TA muscles were quickly
dissected and frozen in liquid nitrogen-cooled isopentane and
stored at 280uC until further analyses.
Deoxy glucose measurement
Tibialisanterior muscles were cut in three parts and the middle part
was ground with a N2-cooled mortar and pestle. After homogenisa-
tion, the samples were heated to 99uC for 30 min, cooled and
centrifuged for 5 min at 13,000 rpm. 2-deoxy-[1-3H]-D-glucose-
phosphate was separated from 2DG in the supernatant by binding to
a Dowex column (Dowex 1*8-100, ion exchange resin, Sigma).
Bound 2-deoxy-[1-3H]-D-glucose-phosphate was eluted from the
column by using the eluate buffer (formic acid, ammoniumacetate in
mQ, pH 4.9). 14 ml LCD scintillation fluid was added to 1 ml eluate,
and this cocktail was counted in the scintillation counter for 5 min.
Histological analysis of intramyocellular lipids (IMCL) and
quantification of DGAT1
Cryosections (5 mm) from the midbelly region of the TA muscle
were stained for neutral lipids with Oil Red O and DGAT1
overexpresssion was quantified as previously described [15].
Electron microscopy
In a subset of 4 CHOW and 4 high-fat fed mice both the
DGAT1 overexpressing muscle as well as the empty-vector control
condition were processed for routine transmission electron
microscopy. In brief, small blocks of muscle tissue (2*2*2 mm)
from both legs were fixed by glutaraldehyde and post-fixed by
DGAT1 Induced Lipid Turnover
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crons) were cut to confirm longitudinal fiber orientation by light
microscopy. Subsequently, ultrathin (80–90 nm) sections were cut
and stained and contrasted with uranyl acetate and lead-citrate.
Then, sections were examined in a Philips CM100 transmission
electron microscope (Philips, Eindhoven, The Netherlands). Per
muscle 15–20 images were grabbed and analyzed by an
experienced electron microscopist blinded for the conditions.
Using the NIH image analysis program all individual lipid droplets
were identified, counted and encircled to compute lipid droplet
area and derived morphometric parameters. Frequency distribu-
tions were computed and plotted using Excel for Windows.
DAG measurement
Total lipids were extracted from frozen muscle using the
method of Folch et al. [23]. The extracts were filtered and lipids
recovered in the chloroform phase. DAG was isolated using thin-
layer chromatography on Silica Gel 60 A plates developed in
petroleumbenzin-diethyl ether-acetic acid (120:25:1.5 by volume)
and visualized by rhodamine 6G. The DAG band was scraped
from the plate and methylated using a mixture of toluene-
methanol- (BF3/methanol 14%) (20%-55%-25% by volume), as
described by Morrison and Smith [24]. The methylated fatty acids
were extracted with hexane and analyzed by capillary gas liquid
chromatography using a 50 m 60.25 mm CP-sil 88 silica column
(varian) with helium as carrier gas at a flow of 130 kPa. The
column oven was maintained at 165uC for 10 min and increased
at a rate of 5uC/min to 190uC. This temperature was maintained
for 15 min. Then temperature was increased to 230uC for 22 min
with a flow rate of 2uC/min. Fatty acid methyl esters were
identified by comparing retention times to those of known
standards. Inclusion of an internal standard, 19:0 (dinonadecanoic
acid), and an average molecular mass for each fatty acid methyl
ester permits quantification of the amount of DAG in the sample,
expressed as micromolar per gram of wet tissue weight.
Ceramide measurement
Ceramide content was determined as previously described (25)
with slight modifications. Briefly, 50 ml of muscle homogenate was
extracted with 600 ml of CHCl3/MeOH 1/2 (vol/vol). The extract
was centrifuged for 10 min at 14,000 g and the pellet discarded.
500 ml of CHCl3/MQ-H2O 1/1.5 (vol/vol) was added, mixed,
and centrifuged for 3 min at 14,000 g to separate the phases. The
lower phase was collected and the upper phase re-extracted with
400 ml of CHCl3. The combined lower phases were dried under
N2 flow, taken up in 500 ml of freshly prepared 0.1 M NaOH in
MeOH, and deacetylated in a microwave (SAM-155, CEM corp.)
for 60 min. 50 ml of this solution was derivatized with 25 ml o-
phtaldehyde (OPA) reagent. The OPA-derivatized lipids were
separated by HPLC and ceramides were quantified as previously
described, using C17 sphinganine as an internal standard [25].
Western blotting
Muscle samples were homogenized as described previously [26]
and processed for standard SDS-PAGE and Western blotting.
Protein concentration was assessed, and equal amounts of protein
were loaded per lane. Actin was used as a loading control.
Membranes were incubated with antibodies against OXPAT
(GP31, Progen, Heidelberg, Germany), OXPHOS (MS601;
MitoSciences, Eugene, OR, USA), PGC1a (516557; Calbiochem;
VWR International BV, Amsterdam, The Netherlands) and
mUCP3 [27], ADRP (GP40, Progen), ATGL (2138; Cell Signalling
Technology; Bioke ´; Leiden, The Netherlands) and CGI58 (NB110-
41576; Novus Biologicals, Littleton, CO, USA). Blots incubated
with OXPAT, OXPHOS, PGC1a and mUCP3 were probed with
IRDye800-conjugated or IRDye700-conjugated secondary anti-
bodies (Rockland, Gilbertsville, PA, USA and LICOR Biosciences,
Westburg, Leusden, The Netherlands), and bands at a molecular
weight corresponding to the control samples were quantified using
the Odyssey infrared imaging system (LICOR Biosciences, Water-
ingen, the Netherlands). Blots detecting ADRP, ATGL and CGI58
were probed with the appropriate horse radish-conjugated
antibodies and after incubation specific protein bands were
visualized by chemiluminescence and analyzed by Chemidoc
XRS system (Bio-Rad, Veenendaal, The Netherlands).
Statistics
Results are presented as means 6 SEM. Differences between
legs within one rat were analysed by paired samples t-test. Between
groups, differences were analysed with an independent t-test. The
accepted level of statistical significance was p,0.05 for all
analyses. Al calculations were done using the Statistical Package
for the Social Sciences (SPSS 16.0 software).
Results
Body mass
Body mass gradually increased over the three weeks of dietary
intervention in both the CHOW- and HFD-fed rats. However,
this short-term dietary intervention did not result in differences in
body mass between diets (300610 g and 290610 g in HFD- vs.
CHOW-fed rats, p=0.70).
DGAT1 overexpression, intramyocellular lipid levels
One week after electroporation, immunohistochemistry revealed
a widely distributed DGAT1 overexpression in the muscle fibres of
left TA muscle of rats; both in rats receiving the HFD as well as the
CHOW. The mean green intensity of images from the DGAT1
electroporated leg was significantly higher than observed in the
sham-electroporated contralateral control leg (25.7762.09 AU vs.
8.3261.68 AU in HFD-DGAT1 vs. HFD-control, p,0.001, and
25.7363.17 AU vs. 7.3761.79 AU in CHOW-DGAT1 vs.
CHOW-control, p,0.001), indicating significant overexpression of
DGAT1. The DGAT1 overexpression was associated with a ,52%
increase in intramyocellular lipids in the HFD-DGAT1 overex-
pressing leg and a ,66% increase in muscle triglyceride content in
theCHOW-DGAT1overexpressingleg,comparedtocontrollegsof
the animals (p=0.018, HFD-DGAT1 vs. HFD-control leg, and
p=0.044, CHOW-DGAT1 vs. CHOW-control leg, figure 1).
Diacylglycerol content
To determine whether the increased IMCL content in TA
muscle overexpressing DGAT1 was accompanied by a reduction
of DAG, we measured the latter in the legs overexpressing
DGAT1 as well as in their empty vector control legs (figure 2).
Three weeks of high-fat feeding was associated with a ,75%
increase in DAG content (p=0.039). Remarkably, overexpressing
DGAT1 led to a ,30% increase in DAG content in the HFD-
DGAT1 overexpressing leg and a ,35% increase in DAG content
in CHOW-DGAT1 overexpressing leg, compared to control legs
of the animals (p=0.073, HFD-DGAT1 vs. HFD-control leg, and
p=0.045, CHOW-DGAT1 vs. CHOW-control leg).
Ceramide content
Ceramide content was measured in TA muscle overexpressing
DGAT1 and in the contralateral empty vector electroporated legs
to determine whether the increase in IMCL content is linked to
changes in muscle ceramide levels (figure 3). Compared the
DGAT1 Induced Lipid Turnover
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increase ceramide content in TA muscle. Furthermore, also
DGAT1 overpression did not affect ceramide levels both in
CHOW-DGAT1 overexpressing legs and in HFD-DGAT1
overexpressing legs compared to their controls, respectively.
Insulin sensitivity
One week after electroporation of DGAT1 whole-body and
tissue insulin sensitivity were assessed in vivo by hyperinsulinemic-
euglycemic clamps in combination with radioisotope-labelled
infusion of 2-deoxy-[3H]glucose (2DG). Compared to CHOW-
fed animals, three weeks of high-fat feeding induced whole body
insulin resistance as reflected by a significantly lower glucose
infusion rate (30.461.2 mg/min/kg vs. 35.261.3 mg/kg/min in
HFD- vs. CHOW-fed animals, p=0.02, figure 4A). In CHOW
fed rats, 2DG uptake was significantly elevated in DGAT1
overexpressing TA muscle compared to their empty vector control
legs (p=0.036, figure 4B). Also upon high-fat feeding, DGAT1
overexpression significantly increased 2DG uptake in TA muscle
compared to the empty vector control legs of these rats (p=0.05,
figure 4C). These results were not confounded by altered basal
GLUT4 expression, as this was not affected by DGAT1
overexpression (data not shown).
Markers of mitochondrial function and biogenesis
(OXPHOS, PGC1a, UCP3)
To test if the increase in lipid content in DGAT1 overexpressing
muscle was accompanied by a compensatory increase in
mitochondrial capacity, we determined protein levels of major
mitochondrial markers. DGAT1 overexpression was associated
with a ,32% increase in PGC1a in the HFD-DGAT1
overexpressing leg compared to the control leg of the animals
(p=0.04, figure 5A), suggesting an increased mitochondrial
biogenesis. High fat feeding did not affect the PGC1a content in
TA muscle. DGAT1 overexpression in CHOW animals had no
significant effect on PGC1a expression (p=0.64, figure 5A).
Western blotting of the OXPHOS complexes revealed that
DGAT1 overexpression, in rats fed a HFD, led to an increase in
protein levels of the individual complexes I, III and V, suggesting
an increased mitochondrial density (Complex I: 1.260.4 AU vs.
0.8660.26 AU, p=0.007, Complex II: 0.9760.31 AU vs.
0.9860.31 AU, p=0.89 Complex III: 1.060.32 AU vs.
0.7760.23 AU, p=0.0023, Complex V: 1.060.30 AU vs.
0.8960.26 AU, p=0.014 in HFD-DGAT1 vs. HFD-control leg,
figure 5B). DGAT1 overexpression did not enhance mitochon-
drial density in rats receiving CHOW represented as differences in
protein expression of the individual complexes (Complex I:
0.9560.39 AU vs. 0.9260.37 AU, p=0.72, Complex II:
Figure 1. Electroporation of DGAT1 in TA muscle of rats on
CHOW and HFD is associated with an increased partitioning of
fatty acids towards IMCL. IMCL levels after three weeks of dietary
intervention, area fraction reflects the percentage of the total measured
cell surface covered by lipid droplets. Data are expressed as mean 6
SEM (n=10–12). *P,0.05 CHOW-DGAT1 vs. CHOW-control,
# P,0.05
HFD-DGAT1 vs. HFD-control.
doi:10.1371/journal.pone.0014503.g001
Figure 2. Three weeks of high-fat feeding is associated with an
increased TA DAG content compared to rats on CHOW. DGAT1
overexpression leads to an increase in TA DAG content in rats on CHOW
and tended to increase DAG content in rats on HFD. Data are expressed
as mean 6 SEM (n=6). *P,0.05 CHOW-DGAT1 and HFD-control vs.
CHOW-control.
doi:10.1371/journal.pone.0014503.g002
Figure 3. Three weeks of high-fat feeding is not associated with
an increased TA ceramide content compared to rats on CHOW.
DGAT1 overexpression does not result in an increase in TA ceramide
content in rats on CHOW or HFD. Data are expressed as mean 6 SEM
(n=10–12).
doi:10.1371/journal.pone.0014503.g003
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0.8360.29 AU vs. 0.9760.34 AU, p=0.35, Complex V:
0.9460.30 AU vs. 1.0660.34 AU, p=0.20 in CHOW-DGAT1
vs. CHOW-control leg, figure 5B). Western blotting of UCP3
revealed a marked ,33% decrease in protein content after
overexpression of DGAT1 in HFD-fed rats, which was nearly
significant (p=0.09, HFD-DGAT1 vs. HFD-control leg,
figure 5C). UCP3 protein levels were not significantly different
between the HFD-DGAT1 overexpressing leg and both the
CHOW-DGAT1 and CHOW-control legs (p=0.88, CHOW-
DGAT1 vs. CHOW-control leg, figure 5C).
Electron microscopy, OXPAT
Oil Red O staining showed a marked increase in the number of
intramyocellular lipid droplets upon DGAT1 overexpression, both
in CHOW- and HFD-fed animals. However, electron microscopy
revealed that DGAT1 overexpression on CHOW resulted in a
massive increase in the number of lipid droplets of submicron size,
which do not exceed the detection limit of light microscopy
(figure 6A, upper panel). Upon high-fat feeding however,
DGAT1 overexpression mainly increased the size of the lipid
droplets, rather than the number (figure 6A lower panel). In
contrast, in CHOW-fed rats, DGAT1 overexpression did not
further increase the diameter of the lipid droplets (Figure 6A,
upper panel). The increased size of the lipid droplets in the
HFD-DGAT overexpressing leg, compared to the empty-vector
control leg, corresponded with an increase in the lipid droplet
coating protein OXPAT (p=0.08, HFD-DGAT1 vs. HFD-
control leg, and p=0.14, CHOW-DGAT1 vs. CHOW-control
leg, figure 6B).
ATGL, CGI58, ADRP
The finding that IMCL, DAG and markers of oxidative
capacity were increased in DGAT1 overexpressing muscle may
suggest that the turnover of IMCL is increased in the insulin-
sensitive DGAT1 overexpressing legs. To test this hypothesis we
determined the protein expression of ATGL and CGI58 as
markers of intramyocellular triglyceride lipolysis. DGAT1 over-
expression was associated with a ,35% increase in ATGL content
in the HFD-DGAT1 overexpressing leg compared to the control
leg of the animals (p=0.04, HFD-DGAT1 vs. HFD-control leg,
figure 7A). DGAT1 overexpression in CHOW-fed rats tended to
further enhance the ATGL protein content (p=0.06, CHOW-
DGAT1 vs. CHOW-control leg, figure 7A). Western blotting of
CGI58, a cofactor of ATGL showed similar results. DGAT1
overexpression led to a ,25% increase in CGI58 protein in the
HFD-DGAT1 overexpressing leg compared to the control leg of
the animals (p=0.009, HFD-DGAT1 vs. HFD-control leg,
figure 7B). DGAT1 overexpression in CHOW animals did not
affect CGI58 protein expression (p=0.16, CHOW-DGAT1 vs.
CHOW-control leg, figure 7B). Accordingly, ADRP, a lipid
droplet coating protein suggested to be involved in the regulation
of lipolysis, was ,25% increased in the HFD-DGAT1 overex-
pressing leg compared to the control leg of the animals (p=0.05,
HFD-DGAT1 vs. HFD-control leg, figure 7C). DGAT1
overexpression in CHOW animals had no effect on ADRP
Figure 4. Three weeks of high-fat feeding compared to rats on CHOW decreased whole-body insulin sensitivity as assessed by
hyperinsulinemic eulgycemic clamp. DGAT1 overexpression in TA muscle increased muscle specific insulin sensitivity both in rats on CHOW as
HFD. (A) Steady-state whole-body glucose infusion rates in rats on CHOW and HFD for three weeks. (B) 2DG uptake in TA muscle of CHOW fed rats
after bolus injection of 2-deoxy-[3H]glucose under the same clamping conditions as in A. (C) 2DG uptake in TA muscle of HFD fed rats after bolus
injection of 2-deoxy-[3H]glucose under the same clamping conditions as in A. Data are expressed as mean 6 SEM (n=10–12). *P,0.05 CHOW-DGAT1
and HFD-control vs. CHOW-control,
# P,0.05 HFD-DGAT1 vs. HFD-control.
doi:10.1371/journal.pone.0014503.g004
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PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e14503expression (p=0.90, CHOW-DGAT1 vs. CHOW-control leg,
figure 7C).
Discussion
Elevated IMCL levels have been associated with thedevelopment
of insulin resistance. Yet, insulin-sensitive, endurance trained
athletes are also characterized by high IMCL levels. It has therefore
been suggested that not IMCL, but rather intermediates of
intramuscular triglyceride metabolism, such as DAG are causally
related to insulin resistance. DGAT1 converts DAG into TAG in
skeletal muscle, and increased DGAT1 activity has been suggested
to explain the athlete’s paradox [14,16,17]. In this study we show
that DGAT1 overexpression in muscle of adult male Wistar rats
indeed augments the storage of IMCL, but remarkably also results
in increased skeletal muscle DAG content, even though a marked
improvement in insulin sensitivity was observed. Our results suggest
thatincreasedintramuscularDAGandTAG turnovermayunderlie
the beneficial effects on muscle insulin sensitivity.
In our study, short-term overexpression of DGAT1 resulted in a
significantly higher intramyocellular lipid content both after
CHOW and HFD, as expected based upon the primary function
Figure 5. DGAT1 overexpression is associated with an increased mitochondrial function and biogenesis in HFD-fed rats. (A) Western
blot analysis of PGC1a (B) OXPHOS complexes and (C) UCP3 in rat TA muscle. Data are expressed as mean 6 SEM (n=10–12).
# P,0.05 HFD-DGAT1
vs. HFD-control.
doi:10.1371/journal.pone.0014503.g005
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overexpression of DGAT1 in animals receiving the HFD mainly
resulted in an increased size of the lipid droplets, rather than an
increased number. The increase in lipid droplet size in the HFD-
DGAT1 overexpressing leg, compared with the empty vector
control leg, was associated with an increase in the content of the
lipid droplet coating proteins OXPAT and ADRP, which are
thought to play a role in lipid synthesis and breakdown [28]. In
CHO cells it was shown that ADRP is ubiquitinated and degraded
by proteolysis when TAG levels decreased whereas inhibition of
ADRP proteolysis led to a 2.8 fold increase in TAG levels [29].
Furthermore, improvement of human skeletal muscle insulin
Figure 7. The turnover of DAG and TAG is increased in the DGAT1 overexpressing TA muscle. (A) Western blotting of ATGL, (B) CGI58 (C)
and ADRP in rat TA muscle. Data are expressed as mean 6 SEM (n=10–12).
# P,0.05 HFD-DGAT1 vs. HFD-control.
doi:10.1371/journal.pone.0014503.g007
Figure 6. DGAT1 overexpression results in bigger lipid droplets in HFD-fed rats. (A) Electron microscopy revealed an increase in lipid
droplet diameter in DGAT1 overexpressing TA muscle of HFD-fed rats. (B) Western blot analysis of OXPAT in rat TA muscle. Data are expressed as
mean 6 SEM (n=10–12).
doi:10.1371/journal.pone.0014503.g006
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These data suggest that hydrolysis of TAG in lipid droplets might
indeed be under control of ADRP. Also, OXPAT seems to
promote long-chain fatty acid oxidation besides being involved in
fatty acid-induced triacylglycerol accumulation [31].
By converting fatty acyl-CoA and DAG into TAG, DGAT1 is
considered to modulate the levels of the lipotoxic fatty acid
derivate DAG, which is marked as a possible causative fatty acid
intermediate in the onset of insulin resistance [17]. Paradoxically,
to our knowledge, this study is the first to show that myocellular
DAG levels were increased upon muscle specific DGAT1
overexpression. The present study showed an increase in total
DAG content upon DGAT1 overexpression in TA muscle
compared to the empty-vector control leg, which was most
pronounced upon high-fat feeding. In line with our observation, it
has recently been shown by others that muscle-specific overex-
pression of DGAT1 resulted in a profound increase in IMCL [17].
In their model though, the increase in IMCL was associated with a
reduction in muscle DAG content. Recently, the same group
showed that muscle-specific transgenic overexpression of DGAT1
in mice enhanced muscle triglyceride synthesis as reflected by the
70% increase in muscle IMCL content; however, no data were
reported on muscle DAG content [14]. In interpreting our results
it is important to keep in mind that we used a specific muscle-
orientated model to unilaterally overexpress DGAT1. Therefore,
the effect of DGAT1 overexpression in muscle can be compared to
control muscle in the same animal, preventing the influence of
systemic differences, which are likely to interfere the comparison
between a transgenic animal and a wild-type control. Indeed, the
transgenic overexpression of DGAT1 by use of a muscle-specific
MCK promotor also resulted in differences in body weight gain
[14,17]. The advantage of our model is that such whole-body
phenotypic changes are prevented, allowing the conclusion that
the results obtained in our study are truly muscle-specific.
In agreement with our hypothesis that increasing the lipogenic
capacity of skeletal muscle can improve insulin sensitivity, the
results of the present study indicate that DGAT1 overexpression
did improve skeletal muscle insulin resistance. DGAT1 overex-
pression in left TA muscle of high-fat-fed rats was associated with a
,16% higher uptake of bolus-injected 2DG in skeletal muscle
compared to the sham-electroporated right leg of the animals.
Previous studies confirm the maintenance of insulin sensitivity in
skeletal muscle overexpressing DGAT1 by increasing the storage
of fatty acids inside the muscle as TAG [14,16,17]. Moreover,
these insulin-sensitizing effects observed in skeletal muscle
overexpressing DGAT1 recapitulates the findings induced by
exercise training, a phenomenon referred to as the athlete’s
paradox. Indeed, Liu et al. [17] compared the effects of
upregulating myocellular DGAT1 expression with exercise and
found that the mechanism underlying insulin sensitivity was
similar in both conditions, namely the channelling of reactive fatty
acid substrates into storage in the form of TAG. These results
suggest that exercise-induced DGAT1 activation may explain the
athlete’s paradox. Here we confirm that DGAT1 overexpression
may improve insulin sensitivity, but not via a decrease in total
DAG content, but rather an elevated DAG content, although we
can not exclude the possibility that a subfraction of ‘‘active’’ DAG
was decreased in our study. Very interestingly, it was recently
shown that endurance trained athletes are also not characterized
by low, but rather by increased DAG levels in skeletal muscle [32],
consistent with our observation of elevated DAG levels and
improved insulin sensitivity. From these and our results, we
suggested that increased turnover of DAG and TAG, especially
upon high-fat feeding, may be beneficial for muscle insulin
sensitivity. Accordingly, ATLG protein expression - the main
triglyceride lipase in myotubes and in rat skeletal muscle [33] - was
significantly elevated upon DGAT1 overexpression in left TA
muscle of both HFD- and CHOW-fed rats compared to their
control legs respectively. Moreover, the expression of CGI-58, an
activating cofactor of ATGL [34], was significantly upregulated
upon DGAT1 overexpression in rats receiving the HFD. Also, the
lipid droplet coating protein ADRP, which is known to interact
with CGI58 to regulate the access of this co-activator to the TAG
stores, was significantly upregulated in the leg of HFD-fed rats
subjected to DGAT1 overexpression [35,36]. Hence, these data
suggest that skeletal muscle triglyceride lipolysis may have been
increased upon DGAT1 overexpression upon high-fat feeding.
Again, this may resemble the endurance-trained state, as some
[37] but not all endurance training studies [38,39] observe an
increase in ATGL content, indicating that the utilization of IMCL
is increased.
In endurance training, increased muscle lipid content is
balanced by elevated mitochondrial oxidative capacity [40,41],
allowing the oxidation of liberated fatty acids. Interestingly, in our
overexpression model we show an increase in total OXPHOS
protein content in the DGAT1 overexpressing TA muscle in rats
receiving a HFD compared to their empty vector control legs. This
pattern of protein expression was also shown for the individual
complexes I, II and V of the OXPHOS complexes. In CHOW-fed
animals, DGAT1 overexpression did not further enhance the
expression level of the OXPHOS complexes. Also, PGC1a protein
content, a marker of mitochondrial biogenesis, was significantly
upregulated in the DGAT1 overexpressing leg of animals receiving
a HFD, whereas no effect of DGAT1 overexpression on PGC1a
protein levels were noticed upon CHOW-feeding. We have
previously shown – as reviewed in [42] – that UCP3 protein
content is elevated under conditions when fatty acid supply
exceeds oxidative capacity, such as high-fat feeding and fasting,
and UCP3 is reduced when oxidative capacity increases as is the
case with endurance training. In line with our hypothesis, UCP3
was upregulated by HF feeding in the sham-electroporated leg, but
DGAT1 overexpression reversed the increase in UCP3 protein
content to levels observed in CHOW. This matches with the
observed increase in the capacity of oxidative substrate degrada-
tion upon DGAT1 overexpression. These findings implicate that
especially in case of increased delivery of free fatty acids (i.e. high
fat feeding) to skeletal muscle, enhanced intramuscular lipid
turnover together with the improvement in markers of mitochon-
drial function and biogenesis might be responsible for the
improved skeletal muscle insulin sensitivity, even despite elevated
muscle DAG levels.
Next to DAG, other fatty acid intermediates have been
suggested to interfere with muscle insulin signalling. Thus, several
studies have implicated a role for ceramides in the development of
insulin resistance in conditions of increased fatty acid supply to
skeletal muscle [43,44,45,46]. Moreover, conditions of increased
DGAT1 expression, such as exercise training [40,47] have been
linked to reductions in ceramide levels. Therefore, theoretically the
insulin-sensitizing effect of DGAT1 overexpression could be due to
reductions in ceramide levels. However, in our study, muscle
ceramide content was not affected by increasing the intramyocel-
lular lipid storage through DGAT1 overexpression, neither in
animals on CHOW or on HFD. Thus, it seems that by specifically
stimulating triglyceride biosynthesis in skeletal muscle, fatty acids
are not directed towards de novo ceramide synthesis. More
important, it shows that the positive effects of DGAT1
overexpression in muscle insulin sensitivity in our study could
not be attributed to changes in ceramides levels. Alternatively, the
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also linked to insulin resistance in conditions of high fatty acid
availability [48]. In our study, we observed that DGAT1
overexpression improved muscle insulin sensitivity in parallel with
increased expression of markers of mitochondrial function such as
PGC1a as well as the OXPHOS complexes. Liu et al. [14] also
reported that DGAT1 overexpressing muscles appeared to have a
greater mitochondrial fatty acid oxidation efficiency. These data
could suggest that in our model acylcarnitines may be reduced,
thereby explaining the improved insulin sensitivity. Unfortunately,
due to the limited amount of muscle sample available and our
prioritization of DAG and ceramide analysis, the reliable
determination of long- and medium-chain acylcarnitines was not
possible. However, we could reliably measure levels for free
carnitine and acetylcarnitine, which were unaffected by our
intervention. In general, increases in long-chain acylcarnitines are
reflected in decreased free carnitine and acetylcarnitine levels [48].
The lack of effect of DGAT1 overexpression on free carnitine and
acetylcarnitine levels therefore make it less likely that levels of
acylcarnitines were changed in our current study.
Overall, we provide support for the hypothesis that in case of
increased supply of fatty acids to skeletal muscle, as is the case with
high-fat feeding, DGAT1 overexpression can improve insulin
sensitivity. Interestingly, DGAT1 overexpression did not do so by
lowering DAG, but more likely by increasing DAG and TAG
turnover. Seemingly, by overexpressing DGAT1, a tight coupling
between lipogenic and lipolytic pathways ensues and the capacity
to oxidize fatty acids is upregulated in order to match the amount
of fatty acids that are being offered. Apparently, only when there is
a proper balance between the supply and oxidation of fatty acids in
skeletal muscle, the lipid intermediate DAG may not exert harmful
effects on insulin signalling.
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